There are 1 companies tagged `t-spot-tb`; raised $105.1M from 24 investors

Oxford Immunotec raised $105.1M from Imperial Innovations, Invesco Perpetual, Clarus Ventures, New Leaf Venture Partners, DFJ Esprit, Wellington Partners, Spark Ventures, Kaiser Permanente Ventures, New Leaf Venture Partners, Kaiser Permanente Ventures, Clarus Ventures, Wellington Partners, Spark Ventures, DFJ Esprit, University Of Oxford, Clarus Ventures, Wellington Partners, NTEC, Prelude Trust, Quester Capital, The Dow Company, Prelude Trust, Quester Capital, and The Dow Company in 4 rounds.

Oxford Immunotec Raises $28M in Equity Financing Oxford Immunotec, Ltd.: Series D $26M Oxford Immunotec Completes $40M Financing Oxford Immunotec gets 7m [pounds sterling] to broaden reach of TB test.